Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Many organizations are thinking about population health and consider it “critically important” to the future of healthcare, but few are in any payer agreements, according to findings from Numerof & Associates.
An article published earlier this week by Crain’s New York Business examined the two extremes of New York hospitals and a possible way to close that gap.
Medical technology company Stryker plans to acquire Cary, Ill.–based Sage Products, which manufactures a host of products meant to prevent so-called “never events” in ICUs and hospitals, including hospital-acquired infections.
Partners HealthCare is launching a second round of Innovation Discovery Grants (IDG) to support the most promising early-stage ideas that can someday improve patient care.
In an effort to better educate doctors and their patients about the Zika virus, the American Medical Association (AMA) announced today the creation of the Zika Virus Resource Center.
The Center for Data Driven Discovery in Biomedicine at The Children's Hospital of Philadelphia (CHOP) aims to advance precision medicine and match the most appropriate treatment to individual patients.
All adults age 18 and older in the general population—including pregnant and postpartum women—should be screened for depression, according to newly updated guidelines from the United States Preventative Services Task Force (USPSTF).
Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.
When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country.
If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation.